{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:18:46Z","timestamp":1794917926452,"version":"4.9.1"},"reference-count":34,"publisher":"Bentham Science Publishers Ltd.","issue":"7","funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["Grant number: 963799"],"award-info":[{"award-number":["Grant number: 963799"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>In this study, an in situ gel-forming chitosan hydrogel was prepared with the\nuse of glutamate salt of chitosan (Ch-Ga), \u03b2-glycerophosphate (Gp), and morphine (Mor). The paper is\nfocused on in vitro physicochemical properties and in-vivo analgesic effects of the prepared chitosan\nhydrogel.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Method:<\/jats:title>\n<jats:p>The thermosensitive properties of prepared chitosan hydrogel were evaluated during the different\ntemperatures and times. The physicochemical properties of chitosan hydrogel were investigated by infrared\n(IR) spectroscopy and X-ray diffraction analysis (XRD). Also, its cell cytotoxicity effects were evaluated\nin murine NIH\/3T3 normal cells. Subsequently, the distribution of chitosan hydrogel in the nasal cavity of\nrats and its analgesic responses were evaluated. The prepared chitosan hydrogel showed that it could be\ngelled at the temperature of 34 \u00b0C before leaving the nose in the shortest possible time of 30 s.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Result:<\/jats:title>\n<jats:p>The analgesic responses of the intranasal (IN) injection of chitosan hydrogel (IN-chitosan hydrogel,\n10 mg Mor\/kg) in a single unit dose in rat relative to the placebo and intranasal or intraperitoneal\n(IP) injection of free morphine solution (IN-Free Mor or IP-Free Mor, 10 mg Mor\/kg) via the hot plate\ntest, reveal that the IN-chitosan hydrogel could induce fast analgesic effects of morphine with maximum\npossible effect (MPE) of 93% after 5 min compare to the IN-Free Mor and IP-Free Mor with MPE of\n80% after 15 min and 66% after 30 min, respectively. Also, prolonged analgesic effects with MPE of\n78 % after 6 h of injection were only seen in the IN-chitosan hydrogel injected group. The obtained\nfluorescent images of rat\u2019s brain injected with IN-chitosan hydrogel containing doxorubicine (Dox) as a\nfluorescent agent showed that the mucosal adhesive and absorption enhancer properties of IN-chitosan\nhydrogel resulting in longer presence of them in the nasal cavity of rats followed by more absorption of\nDox from the blood vessels of olfactory bulbs with a 74% color intensity compared to the IN-Free Mor\nand IN-Free Dox with 15%.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>These data reveal that the IN-chitosan hydrogel could induce fast and prolonged analgesic\neffects of morphine compare to the IN\/IP-Free Mor, which could be considered as an in situ gel-forming\nthermosensitive chitosan hydrogel for nasal delivery of wide ranges of therapeutic agents.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567201820666230724161205","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T06:13:11Z","timestamp":1690351991000},"page":"1024-1035","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Preparation and Evaluation of the <i>In situ<\/i> Gel-forming Chitosan Hydrogels\nfor Nasal Delivery of Morphine in a Single Unit dose in Rats to Enhance\nthe Analgesic Responses"],"prefix":"10.2174","volume":"21","author":[{"given":"Hossein","family":"Kamali","sequence":"first","affiliation":[{"name":"Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran."},{"name":"Department of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Tafaghodi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran"},{"name":"Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Eisvand","sequence":"additional","affiliation":[{"name":"Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Mohammad","family":"Ahmadi-Soleimani","sequence":"additional","affiliation":[{"name":"Department of Physiology, School of Paramedical Sciences, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Khajouee","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosnieh","family":"Ghazizadeh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafar","family":"Mosafer","sequence":"additional","affiliation":[{"name":"Research Center of Advanced Technologies in Medicine, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran"},{"name":"Health Sciences Research Center, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"235","author":"Pagano C.","year":"2023","unstructured":"Pagano C.; Perioli L.; Ricci M.;  Novel Approaches in Nasal In Situ Gel Drug Delivery Nasal Drug Delivery: Formulations, Developments, Challenges, and Solutions  2023,235-252","journal-title":"Novel Approaches in Nasal In Situ Gel Drug Delivery Nasal Drug Delivery: Formulations, Developments, Challenges, and Solutions"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2174\/1871527320666210902163756","volume":"21","author":"Datusalia A.K.","year":"2022","unstructured":"Datusalia A.K.; Singh G.; Yadav N.; Gaun S.; Manik M.; Singh R.K.; Targeted delivery of montelukast for the treatment of Alzheimer\u2019s Disease. CNS Neurol Disord Drug Targ  2022,21(10),913-925","journal-title":"CNS Neurol Disord Drug Targ"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/pharmaceutics15030829","volume":"15","author":"Georgieva D.","year":"2023","unstructured":"Georgieva D.; Nikolova D.; Vassileva E.; Kostova B.; Chitosan-Based Nanoparticles for Targeted Nasal Galantamine Delivery as a Promising Tool in Alzheimer\u2019s Disease Therapy. Pharmaceutics  2023,15(3),829","journal-title":"Pharmaceutics"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s11064-022-03617-w","volume":"47","author":"Nguyen T.T.","year":"2022","unstructured":"Nguyen T.T.; Bao N.S.; Van Vo G.; Advances in hydrogel-based drug delivery systems for Parkinson\u2019s Disease. Neurochem Res  2022,47(8),2129-2141","journal-title":"Neurochem Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jconrel.2012.01.024","volume":"161","author":"Illum L.","year":"2012","unstructured":"Illum L.; Nasal drug delivery \u2014 Recent developments and future prospects. J Control Release  2012,161(2),254-263","journal-title":"J Control Release"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1213\/ane.0b013e318187b952","volume":"107","author":"Christensen K.S.","year":"2008","unstructured":"Christensen K.S.; Cohen A.E.; Mermelstein F.H.; Hamilton D.A.; McNicol E.; Babul N.; Carr D.B.; The analgesic efficacy and safety of a novel intranasal morphine formulation (morphine plus chitosan), immediate release oral morphine, intravenous morphine, and placebo in a postsurgical dental pain model. Anesth Analg  2008,107(6),2018-2024","journal-title":"Anesth Analg"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/md14050099","volume":"14","author":"Bellich B.","year":"2016","unstructured":"Bellich B.; D\u2019Agostino I.; Semeraro S.; Gamini A.; Ces\u00e0ro A.; \u201cThe Good, the Bad and the Ugly\u201d of Chitosans. Mar Drugs  2016,14(5),99","journal-title":"Mar Drugs"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0378-5173(98)00367-6","volume":"178","author":"Soane R.J.","year":"1999","unstructured":"Soane R.J.; Frier M.; Perkins A.C.; Jones N.S.; Davis S.S.; Illum L.; Evaluation of the clearance characteristics of bioadhesive systems in humans. Int J Pharm  1999,178(1),55-65","journal-title":"Int J Pharm"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0378-5173(01)00602-0","volume":"217","author":"Soane R.J.","year":"2001","unstructured":"Soane R.J.; Hinchcliffe M.; Davis S.S.; Illum L.; Clearance characteristics of chitosan based formulations in the sheep nasal cavity. Int J Pharm  2001,217(1-2),183-191","journal-title":"Int J Pharm"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1023\/A:1018901302450","volume":"11","author":"Illum L.","year":"1994","unstructured":"Illum L.; Farraj N.F.; Davis S.S.; Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res  1994,11(8),1186-1189","journal-title":"Pharm Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","volume":"87","author":"Illum L.","year":"2003","unstructured":"Illum L.; Nasal drug delivery\u2014possibilities, problems and solutions. J Control Release  2003,87(1-3),187-198","journal-title":"J Control Release"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1023\/A:1011929016601","volume":"15","author":"Ilium L.","year":"1998","unstructured":"Ilium L.; Chitosan and its use as a pharmaceutical excipient. Pharm Res  1998,15(9),1326-1331","journal-title":"Pharm Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2165\/00003088-200342130-00003","volume":"42","author":"Davis S.S.","year":"2003","unstructured":"Davis S.S.; Illum L.; Absorption enhancers for nasal drug delivery. Clin Pharmacokinet  2003,42(13),1107-1128","journal-title":"Clin Pharmacokinet"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1016\/j.biomaterials.2006.12.024","volume":"28","author":"Wu J.","year":"2007","unstructured":"Wu J.; Wei W.; Wang L.Y.; Su Z.G.; Ma G.H.; A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system. Biomaterials  2007,28(13),2220-2232","journal-title":"Biomaterials"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/jemt.20545","volume":"71","author":"Iliescu M.","year":"2008","unstructured":"Iliescu M.; Hoemann C.D.; Shive M.S.; Chenite A.; Buschmann M.D.; Ultrastructure of hybrid chitosan-glycerol phosphate blood clots by environmental scanning electron microscopy. Microsc Res Tech  2008,71(3),236-247","journal-title":"Microsc Res Tech"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.01.045","volume":"315","author":"Wu J.","year":"2006","unstructured":"Wu J.; Su Z.G.; Ma G.H.; A thermo- and pH-sensitive hydrogel composed of quaternized chitosan\/glycerophosphate. Int J Pharm  2006,315(1-2),1-11","journal-title":"Int J Pharm"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1021\/bm050313s","volume":"6","author":"Cho J.","year":"2005","unstructured":"Cho J.; Heuzey M.C.; B\u00e9gin A.; Carreau P.J.; Physical gelation of chitosan in the presence of \u03b2-glycerophosphate: the effect of temperature. Biomacromolecules  2005,6(6),3267-3275","journal-title":"Biomacromolecules"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.foodhyd.2005.10.015","volume":"20","author":"Cho J.","year":"2006","unstructured":"Cho J.; Heuzey M.C.; B\u00e9gin A.; Carreau P.J.; Chitosan and glycerophosphate concentration dependence of solution behaviour and gel point using small amplitude oscillatory rheometry. Food Hydrocoll  2006,20(6),936-945","journal-title":"Food Hydrocoll"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0939-6411(03)00161-9","volume":"57","author":"Berger J.","year":"2004","unstructured":"Berger J.; Reist M.; Mayer J.M.; Felt O.; Peppas N.A.; Gurny R.; Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur J Pharm Biopharm  2004,57(1),19-34","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.biomaterials.2006.08.044","volume":"28","author":"Crompton K.E.","year":"2007","unstructured":"Crompton K.E.; Goud J.D.; Bellamkonda R.V.; Gengenbach T.R.; Finkelstein D.I.; Horne M.K.; Forsythe J.S.; Polylysine-functionalised thermoresponsive chitosan hydrogel for neural tissue engineering. Biomaterials  2007,28(3),441-449","journal-title":"Biomaterials"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.3390\/polym14122379","volume":"14","author":"Fan R.","year":"2022","unstructured":"Fan R.; Cheng Y.; Wang R.; Zhang T.; Zhang H.; Li J.; Song S.; Zheng A.; Thermosensitive Hydrogels and Advances in Their Application in Disease Therapy. Polymers (Basel)  2022,14(12),2379","journal-title":"Polymers (Basel)"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/jbm.a.31365","volume":"83A","author":"Hoemann C.D.","year":"2007","unstructured":"Hoemann C.D.; Chenite A.; Sun J.; Hurtig M.; Serreqi A.; Lu Z.; Rossomacha E.; Buschmann M.D.; Cytocompatible gel formation of chitosan-glycerol phosphate solutions supplemented with hydroxyl ethyl cellulose is due to the presence of glyoxal. J Biomed Mater Res A  2007,83A(2),521-529","journal-title":"J Biomed Mater Res A"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1021\/bm7006967","volume":"8","author":"Nair L.S.","year":"2007","unstructured":"Nair L.S.; Starnes T.; Ko J.W.K.; Laurencin C.T.; Development of injectable thermogelling chitosan-inorganic phosphate solutions for biomedical applications. Biomacromolecules  2007,8(12),3779-3785","journal-title":"Biomacromolecules"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"16071","DOI":"10.1038\/natrevmats.2016.71","volume":"1","author":"Li J.","year":"2016","unstructured":"Li J.; Mooney D.J.; Designing hydrogels for controlled drug delivery. Nat Rev Mater  2016,1(12),16071","journal-title":"Nat Rev Mater"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1124\/jpet.301.1.391","volume":"301","author":"Illum L.","year":"2002","unstructured":"Illum L.; Watts P.; Fisher A.N.; Hinchcliffe M.; Norbury H.; Jabbal-Gill I.; Nankervis R.; Davis S.S.; Intranasal delivery of morphine. J Pharmacol Exp Ther  2002,301(1),391-400","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S0885-3924(02)00522-5","volume":"24","author":"Pavis H.","year":"2002","unstructured":"Pavis H.; Wilcock A.; Edgecombe J.; Carr D.; Manderson C.; Church A.; Fisher A.; Pilot study of nasal morphine-chitosan for the relief of breakthrough pain in patients with cancer. J Pain Symptom Manage  2002,24(6),598-602","journal-title":"J Pain Symptom Manage"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1526-4637.2007.00300.x","volume":"9","author":"Stoker D.G.","year":"2008","unstructured":"Stoker D.G.; Reber K.R.; Waltzman L.S.; Ernst C.; Hamilton D.; Gawarecki D.; Mermelstein F.; McNicol E.; Wright C.; Carr D.B.; Analgesic efficacy and safety of morphine-chitosan nasal solution in patients with moderate to severe pain following orthopedic surgery. Pain Med  2008,9(1),3-12","journal-title":"Pain Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/clpt.1993.149","volume":"54","author":"Babul N.","year":"1993","unstructured":"Babul N.; Darke A.C.; Disposition of morphine and its glucuronide metabolites after oral and rectal administration: Evidence of route specificity. Clin Pharmacol Ther  1993,54(3),286-292","journal-title":"Clin Pharmacol Ther"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ijpharm.2016.07.055","volume":"511","author":"Ca\u00f1adas C.","year":"2016","unstructured":"Ca\u00f1adas C.; Alvarado H.; Calpena A.C.; Silva A.M.; Souto E.B.; Garc\u00eda M.L.; Abrego G.; In vitro, ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration. Int J Pharm  2016,511(2),719-727","journal-title":"Int J Pharm"},{"key":"ref=30","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.135735","volume":"748","author":"Ahmadi-Soleimani S.M.","year":"2021","unstructured":"Ahmadi-Soleimani S.M.; Azizi H.; Abbasi-Mazar A.; Intermittent REM sleep deprivation attenuates the development of morphine tolerance and dependence in male rats. Neurosci Lett  2021,748","journal-title":"Neurosci Lett"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2174\/18755704MTA3lOTgqw","volume":"18","author":"Shah P.","year":"2021","unstructured":"Shah P.; Sarolia J.; Vyas B.; Wagh P.; Ankur K.; Kumar M.A.; PLGA nanoparticles for nose to brain delivery of Clonazepam: Formulation, optimization by 32 Factorial design, in vitro and in vivo evaluation. Curr Drug Deliv  2021,18(6),805-824","journal-title":"Curr Drug Deliv"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1213\/ANE.0b013e3182239b8c","volume":"113","author":"Hoekman J.D.","year":"2011","unstructured":"Hoekman J.D.; Ho R.J.Y.; Enhanced analgesic responses after preferential delivery of morphine and fentanyl to the olfactory epithelium in rats. Anesth Analg  2011,113(3),641-651","journal-title":"Anesth Analg"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2174\/1567201816666191029122740","volume":"16","author":"Kashyap K.","year":"2019","unstructured":"Kashyap K.; Shukla R.; Drug delivery and targeting to the brain through nasal route: mechanisms, applications and challenges. Curr Drug Deliv  2019,16(10),887-901","journal-title":"Curr Drug Deliv"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.apsb.2012.07.004","volume":"2","author":"Giri T.K.","year":"2012","unstructured":"Giri T.K.; Thakur A.; Alexander A.; Ajazuddin ; Badwaik H.; Tripathi D.K.; Modified chitosan hydrogels as drug delivery and tissue engineering systems: present status and applications. Acta Pharm Sin B  2012,2(5),439-449","journal-title":"Acta Pharm Sin B"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201820666230724161205","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/219030\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201820666230724161205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T17:11:13Z","timestamp":1713978673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/219030\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567201820666230724161205","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-12-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}